August 09, 2013 at 12:00 PM EDT
RDInvesting Provides Investors with Free In-Depth Equity Reports on MACK, MAKO, SYK and WMGI
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares declined 14.13 percent to close at $3.95 a share Thursday. The stock traded between $3.81 and $4.63 on volume of 6.10 million shares traded. Analysts at Cowen have recently downgraded the company’s rating to “market perform” from “outperform”.
Find out more about Merrimack Pharmaceuticals including full access to the free equity report at:
MAKO Surgical Corp. (NASDAQ: MAKO) shares increased 0.54 percent to close at $14.83 a share Thursday. The stock traded between $14.75 and $15.10 on volume of 918,567 shares traded. Analysts at Robert W. Baird have recently initiated coverage on the company with a “neutral” rating. Shares of MAKO Surgical have gained approximately 15.0 percent year-to-date.
Find out more about MAKO Surgical including full access to the free equity report at:
Stryker Corporation (NYSE: SYK) shares increased 0.16 percent to close at $70.90 a share Thursday. The stock traded between $70.64 and $71.32 on volume of 928,163 shares traded. Analysts at Needham have recently initiated coverage on the company with a “hold” rating. Shares of Stryker have gained approximately 30.0 percent year-to-date.
Find out more about Stryker including full access to the free equity report at:
Wright Medical Group Inc. (NASDAQ: WMGI) shares declined 0.84 percent to close at $27.06 a share Thursday. The stock traded between $26.92 and $27.71 on volume of 1.29 million shares traded. Analysts at Needham have recently initiated coverage on the company with a “buy” rating. Shares of Wright Medical Group have gained approximately 29.0 percent year-to-date.
Find out more about Wright Medical Group including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here